We use cookies to improve your experience. See our Cookie Policy.

    anti aging

    GHK-Cu vs Copper Peptide Complex

    Baltic BioLabs Research Team•April 28, 2026Updated •
    7 min read

    GHK-Cu is a defined copper coordination complex of the tripeptide Gly–His–Lys. Free GHK is approximately 340.38 g/mol; the neutral 1:1 Cu(II) complex represented by PubChem is approximately 401.91 g/mol. Salt forms, protonation and the ion/adduct reported in MS must also be specified.

    “Copper peptide complex” is a broad description that can include GHK-Cu itself or a different formulation. The wording alone does not establish that two products differ. Compare sequence, copper stoichiometry, excipients and lot documentation before deciding whether a substitution changes the experiment.

    Conceptual comparison of copper coordinated with a peptide and separately represented copper and peptide
    Simplified coordination concept. A generic “copper peptide complex” can also be GHK-Cu; composition and lot data determine identity.
    View full-size illustration
    Research Use Only Statement:The products and information provided on this page are intended exclusively for in vitro laboratory research and educational purposes. They are strictly not for human consumption, diagnostic, or therapeutic use. Always adhere to your institution's safety protocols and local regulations when handling these compounds. The subsequent studies and findings referenced are drawn from third-party scientific literature for informational context only and do not constitute professional medical advice.
    Order GHK-Cu (Copper Peptide)
    10% off at checkout
    Apply this code at checkout (final step):

    Quick Comparison Table

    AttributeDefined GHK-CuProduct called “copper peptide complex”
    IdentityGHK coordinated with copper; specify stoichiometry/formMay be the same complex, another peptide or a mixture; inspect documentation
    Mass referencePubChem neutral 1:1 complex approximately 401.91 g/molDepends on identified molecular species and salt/formulation
    Free-peptide distinctionFree GHK approximately 340.38 g/molLabel wording alone does not identify free or bound species
    Comparison requirementSequence, copper content/speciation and assay conditionsSame checks; an unfamiliar name does not establish inferior evidence
    Analytical limitHPLC area purity and intact mass are separate checksNeither guarantees composition, net content or complete sequence

    Use the lot reports to compare actual supplied materials, not a marketing-name hierarchy.

    What is GHK-Cu?

    The sequence provides a defined starting material, but the actual copper species and assay conditions matter. An expected molecular formula is not a guarantee of identical behavior across formulations.

    Free GHK and the Cu Complex

    GHK is Gly–His–Lys. PubChem lists free GHK as C14H24N6O4, about 340.38 g/mol, and the neutral 1:1 copper complex as C14H22CuN6O4, about 401.91 g/mol. The ligand loses protons on coordination, so the complex mass is not simply the free-peptide mass plus copper without accounting for the represented chemistry.

    Reading a Mass Spectrum

    A measured m/z is not automatically a neutral molecular weight. Protonation, charge state, copper isotopes, salts and adducts must be interpreted. A different reported value does not by itself prove that a supplier substituted a non-GHK peptide.

    Copper and Experimental Activity

    Copper coordination can affect chemical behavior, but “copper-bound” should not be used as a universal guarantee of antioxidant action or safe copper delivery. The model, medium and measured endpoint must be identified. Free copper, free GHK and a prepared complex can be useful separate controls.

    What "Copper Peptide Complex" Usually Means

    “Copper peptide complex” is not a unique molecular identifier. It may describe GHK-Cu, a different copper-binding peptide, a mixture or a formulated product. A conclusion about any particular product requires its disclosed composition and lot data.

    For a substitution, compare the sequence, copper-to-peptide ratio, modifications, counterions, excipients and quantitative assay on both products.

    Mechanism - What's Actually Published

    The most useful claims are tied to identifiable experiments, not a broad “younger transcriptome” description.

    Collagen-Synthesis Experiment

    Maquart et al. (1988) reported collagen-synthesis stimulation by the GHK-Cu complex in cultured fibroblasts. A biochemical/culture endpoint is not evidence of cosmetic rejuvenation or clinical wound repair in all settings.

    Disease-Specific Gene Expression

    Campbell et al. (2012) investigated a GHK-related gene-expression signature and human lung fibroblast behavior in the emphysema context. That disease- and cell-specific result does not demonstrate a generally younger state in all human tissue.

    Formulated Products Need Their Own Evidence

    If a product contains additional peptides, carriers or excipients, test that formulation rather than assuming equivalence or inferiority. The defined-molecule literature does not supply a universal ranking of every product described as a copper complex.

    Research Applications Side-by-Side

    For reproducing a published collagen experiment, use the source’s material, medium and endpoint. For a gene-expression question, specify the relevant cell lineage and analysis. For a formulation question, the formulation itself is the experimental object.

    The name GHK-Cu does not, by itself, establish proven hair-growth, mitochondrial rejuvenation or a clinical anti-aging effect. Each of those claims requires a matching experiment or trial; the collagen and emphysema sources cannot stand in for them.

    Choosing for Research

    A documented GHK-Cu material is appropriate when the original protocol used that defined complex. Another product can be equivalent only if its composition and relevant analytical attributes support that conclusion. If the question concerns a commercial blend, study the blend with suitable controls.

    Before purchasing, obtain the lot report, expected molecular species, copper measurement and a quantitative-content basis for stock preparation. See HPLC purity and identity for the analytical distinctions.

    Safety and Regulatory Considerations

    Safety depends on exposure, formulation and route, not simply on whether copper is described as “bound.” The reviewed cell studies do not establish safe systemic human use or prove that one undefined complex is safer than another.

    FDA’s safety-risk page specifically discusses injectable GHK-Cu and limited human safety information. Do not apply a cosmetic-use history or an in-vitro result to a research vial intended for a different exposure.

    Conclusion

    GHK-Cu is a defined copper–peptide complex, while a broad product name requires composition checks. The mass distinction is 340.38 g/mol for free GHK versus about 401.91 g/mol for PubChem’s neutral 1:1 Cu complex. Interpret mass data with charge/adduct and salt information, and keep molecular identity, purity and quantified content separate.

    Source this peptide for your research

    Order GHK-Cu (Copper Peptide)
    10% off at checkout
    Apply this code at checkout (final step):

    Frequently Asked Questions

    Are GHK-Cu and Copper Peptide Complex the same thing?

    They can be. GHK-Cu is a specific copper complex, while “copper peptide complex” can be used for that material or other formulations. Inspect the sequence, copper stoichiometry and lot data. Free GHK is about 340.38 g/mol; the neutral 1:1 Cu complex represented by PubChem is about 401.91 g/mol.

    Which has more peer-reviewed research?

    There are identifiable primary experiments for defined GHK-Cu, including the cultured-fibroblast collagen study. A broad product category cannot be ranked reliably without identifying its constituents and conducting a defined literature search.

    Can I substitute a Copper Peptide Complex product for GHK-Cu in a research protocol?

    Only if the composition and required analytical attributes match the source protocol. A broad label alone does not establish equivalence or non-equivalence. Document sequence, copper-to-peptide ratio, form and excipients before substituting.

    Is GHK-Cu safer than Copper Peptide Complex products?

    The sources here do not establish a universal safety ranking. Exposure, formulation and route matter. Cell experiments and cosmetic history do not establish safe systemic use of a research preparation.

    Where can I source research-grade GHK-Cu?

    Review the lot-specific report for the exact sequence, modifications, HPLC method/trace and interpreted MS result. A compatible intact mass supports composition but is not complete sequence confirmation. If stock concentration matters, obtain a quantitative target-content basis; HPLC area purity is separate from net content. Select acceptance criteria for the model rather than assuming one percentage measures every quality attribute.

    What COA standards should I expect for research-grade GHK-Cu?

    Expect the sequence and represented copper species, lot-linked HPLC method/trace, interpreted MS data, copper content or stoichiometry evidence, and a quantitative peptide/target-content basis when concentration matters. Free GHK is about 340.38 g/mol; a neutral 1:1 copper complex is about 401.91 g/mol. Intact mass alone is not complete sequence or coordination confirmation.

    Does the molecular weight of GHK-Cu vary between suppliers?

    The mass of a specified molecular species is fixed, but reports may describe different salts, protonation states, charges or adducts. Free GHK and GHK-Cu are different species. A number differing from 340 Da is not proof of a substituted peptide; interpret it against the stated form and spectrum.

    Scientific References

    1. PubChem CID 73587: free GHK, 340.38 g/mol - Primary source
    2. PubChem CID 165429100: neutral 1:1 copper complex, 401.91 g/mol - Primary source
    3. Maquart et al. 1988. Collagen synthesis in fibroblasts. PMID: 3169264 - Primary source[PubMed Reference]
    4. Campbell et al. 2012. GHK-related emphysema/fibroblast evidence. PMID: 22937864 - Primary source[PubMed Reference]
    5. FDA. Biotechnology Inspection Guide: structure, mass and purity tests - Primary source
    6. FDA injectable GHK-Cu safety-risk page - Primary source

    Related Research Peptides

    Baltic BioLabs GHK-Cu
    Anti-Aging & Longevity

    GHK-Cu

    Price
    From€34.99
    Live availability is confirmed before checkout
    Select Options
    Baltic BioLabs GLOW Blend (GHK-Cu + BPC-157 + TB-500)
    Dermatology Research

    GLOW Blend (GHK-Cu + BPC-157 + TB-500)

    Price
    €79.99
    Live availability is confirmed before checkout
    Order now
    Baltic BioLabs Epitalon
    Anti-Aging & Longevity

    Epitalon

    Price
    From€45.99
    Live availability is confirmed before checkout
    Select Options

    Continue Reading